- ►annals.org LA Szczech, JA Berlin, HI Feldman - Annals of internal medicine, 1998 - Am Coll Physicians Purpose: Randomized, controlled trials have not shown that the perioperative use of antilymphocyte
antibodies (induction therapy) improves survival of cadaveric kidney allografts. This study combined
individual patient-level data from published trials to examine the effect of induction ... Cited by 78 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org [PDF] LA Szczech, JA Berlin, S Aradhye, RA … - Journal of the American …, 1997 - Am Soc Nephrol Page 1. Effect of Anti-Lymphocyte Induction Therapy on Renal Allograft Survival: A
Meta-Analysis LYNDA ANNE SZCZECH,*t JESSE A. BERLIN,* SHREERAM
ARADHYE,t ROBERT A. GROSSMAN,t and HAROLD I. FELDMAN*t ... Cited by 74 - Related articles - BL Direct - All 4 versions
Y Lebranchu, F Bridoux, M Buchler, Y Le … - American Journal of …, 2002 - interscience.wiley.com Acute graft rejection remains a major problem in renal transplant recipients, and there is no consensus
on the optimal immunosuppressive strategy. Immunoprophylaxis with Thymoglobulin ® or basiliximab
has significantly reduced the incidence of acute rejection episodes and graft loss ... Cited by 81 - Related articles - All 4 versions
H Sollinger, B Kaplan, MD Pescovitz, B Philosophe, A … - Transplantation, 2001 - ncbi.nlm.nih.gov BACKGROUND: Basiliximab (Simulect), a high-affinity chimeric, monoclonal antibody directed
against the alpha chain of human interleukin-2 receptor (CD25), reduces the incidence of acute
renal allograft rejection when used in combination with cyclosporine (Neoral) and ... Cited by 61 - Related articles - BL Direct - All 4 versions
DC Brennan, JA Daller, KD Lake, D Cibrik, D Del … - The New England journal …, 2006 - nejm.org From the Renal Division, Washington Uni- versity School of Medicine, Barnes–Jewish
Hospital, St. Louis (DCB); the Univer- sity of Texas Medical Branch, Galveston (JAD); the Departments
of Internal Medi- cine and Surgery, University of Michigan, Ann Arbor (KDL, DC); and the ... Cited by 93 - Related articles - BL Direct - All 7 versions
B Charpentier, L Rostaing, F Berthoux, P Lang, G … - Transplantation, 2003 - journals.lww.com BERNARD CHARPENTIER,2,32 LIONEL ROSTAING,3 FRANCOIS BERTHOUX,4 PHILIPPE
LANG,5 GIOVANNI CIVATI,6 JEAN-LOUIS TOURAINE,7 JEAN-PAUL SQUIFFLET,8 PAUL
VIALTEL,9 DANIEL ABRAMOWICZ,10 GEORGES MOURAD,11 PHILIPPE WOLF,12 ... Cited by 43 - Related articles - BL Direct - All 4 versions
P Belitsky, AS MacDonald, AD Cohen, J … - Transplantation …, 1991 - ncbi.nlm.nih.gov 1: Transplant Proc. 1991 Feb;23(1 Pt 2):999-1000. Comparison of antilymphocyte
globulin and continuous iv cyclosporine A as induction immunosuppression for
cadaver kidney transplants: a prospective randomized study. ... Cited by 26 - Related articles - All 2 versions
DP SLAKEY, CP JOHNSON, RD CALLALUCE, BJ … - Transplantation, 1993 - journals.lww.com In January 1988, we initiated a prospective, randomized comparison of prophylactic antilymphoblast
globulin (ALG; quadruple therapy) versus no prophylactic ALG (triple therapy) in the setting of
immediate graft function (defined by a brisk diuresis and a 20% decline in serum ... Cited by 26 - Related articles - BL Direct - All 3 versions
G Mourad, V Garrigue, JP Squifflet, T Besse, F … - Transplantation, 2001 - journals.lww.com Skip Navigation Links Home > September 27, 2001 - Volume 72 - Issue 6 > Induction Versus
Noninduction in Renal Transplant Recipients... ... 19 Address correspondence to: Prof. Georges
Mourad, Service de Nephrologie et Transplantation, Hopital Lapeyronie, 371 Av. Du ... Cited by 56 - Related articles - BL Direct - All 5 versions
